These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Analysis of gene structure and antigen determinants of DR2 antigens using DR gene transfer into mouse L cells.
    Author: Kawai J, Ando A, Sato T, Nakatsuji T, Tsuji K, Inoko H.
    Journal: J Immunol; 1989 Jan 01; 142(1):312-7. PubMed ID: 2462589.
    Abstract:
    Three HLA class II DR beta genes and one DR alpha gene from the DR2 haplotype were cloned in cosmid vectors. The DR beta II gene might be a pseudogene lacking the first exon that encodes the leader peptide. The DR beta I and DR beta III genes were expressed, together with the DR alpha-chain, after transfection into mouse L cells. Restriction enzyme mapping of the DR beta genomic clones and reactivity of their products expressed on the L cell transfectant against mAb showed that the DR beta I and DR beta III genes encoded the nonpolymorphic and polymorphic DR beta chain, respectively. This arrangement is the reverse of that observed in other haplotypes, such as DR3, 4 and 6. The alignment of the HLA class II genes including the DR beta genes on the chromosome 6, however, was consistent with other haplotypes, e.g., centromere-DX beta-DX alpha-DV beta-DQ beta-DQ alpha-DR beta I-DR beta II- DR beta III-DR alpha-telomere. These results suggest that the susceptibility to mutations or gene conversions responsible for genetic polymorphisms depends on the gene itself and not on its location. Furthermore, absorption experiments of anti-DR2 allosera by the DR alpha/DR beta transfectants revealed that the so-called DR2 specificities were determined by multiple epitopes although both the DR beta I and DR beta III genes behaved similarly with DR2-specific antibodies.
    [Abstract] [Full Text] [Related] [New Search]